huCART19-IL18-eDHFR cells

· University of Pennsylvania

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for huCART19-IL18-eDHFR cells, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma [Phase 1]